Continuous glucose monitoring technology has undergone a remarkable democratization. Devices that once existed exclusively in endocrinology clinics — available only to patients with insulin-dependent diabetes — now attract a growing population of metabolically healthy individuals who want real-time insight into how their bodies process the food they eat. This expansion from clinical necessity to wellness tool has created a diverse market with options serving very different needs at very different price points.
For people with diabetes, continuous glucose monitors provide life-changing data that finger-stick testing alone cannot deliver. Seeing glucose trends in real time — the rise after a meal, the overnight stability or instability, the impact of exercise and stress — transforms blood sugar management from a series of disconnected snapshots into a continuous narrative that reveals patterns invisible to traditional monitoring.
For metabolically healthy individuals, CGMs offer a window into how specific foods, exercise patterns, sleep quality, and stress levels influence their glucose response. This biofeedback can inform dietary choices, optimize meal timing, and identify individual food sensitivities that standard nutritional guidance misses. Whether this wellness application justifies the cost is a personal decision, but the data these devices provide is undeniably illuminating.
Understanding the differences between available CGM systems — their accuracy, usability, features, and costs — helps both diabetic patients and wellness users select the device that best matches their monitoring goals.
How Continuous Glucose Monitors Work
All CGMs share the same basic mechanism. A tiny flexible sensor filament, thinner than a human hair, is inserted just beneath the skin — typically on the back of the upper arm or the abdomen — where it rests in the interstitial fluid that surrounds cells. This sensor measures glucose concentration in the interstitial fluid rather than directly in the blood, which introduces a physiological time lag of approximately five to fifteen minutes between blood glucose changes and interstitial fluid glucose changes.
The sensor communicates with a transmitter that either sits atop the sensor or is integrated into the sensor housing. The transmitter sends glucose data wirelessly — via Bluetooth or NFC — to a receiver device, smartphone app, or both. Most modern CGMs provide readings every one to five minutes, generating 288 to 1,440 data points per day compared to the three to eight data points that even diligent finger-stick testing provides.
The sensor lifespan varies by manufacturer and model, ranging from seven to fifteen days before requiring replacement. Sensor insertion is performed by the user at home using an applicator device that makes the process largely painless — most users describe feeling a brief pinch or nothing at all.
A critical concept in CGM technology is the Mean Absolute Relative Difference, or MARD — the standard measure of CGM accuracy. MARD represents the average percentage difference between the CGM reading and a simultaneous blood glucose reference measurement. Lower MARD values indicate higher accuracy. Clinical-grade CGMs designed for diabetes management typically achieve MARD values below 10 percent, while some wellness-oriented platforms use the same hardware but present data differently through their companion apps.
Dexcom CGM Systems
Dexcom has established itself as the accuracy leader in continuous glucose monitoring, with its latest generation systems achieving MARD values among the lowest of any consumer CGM. The Dexcom G7 system features a slim, integrated sensor-transmitter unit roughly the size of a small coin that adheres to the skin and provides continuous glucose readings every five minutes for up to ten days.
The Dexcom G7 communicates directly with both iPhone and Android smartphones through a dedicated app that displays real-time glucose values, trend arrows indicating the direction and rate of glucose change, and historical graphs showing glucose patterns over hours, days, and weeks. Customizable high and low glucose alerts notify users when their glucose exceeds or drops below set thresholds — a potentially lifesaving feature for insulin-dependent diabetics at risk for hypoglycemia.
Dexcom's share feature allows designated followers — family members, caregivers, or partners — to monitor glucose readings in real time on their own smartphones. For parents of children with Type 1 diabetes, this remote monitoring capability provides peace of mind during school hours, sleepovers, and other times when direct supervision is not possible.
The Dexcom Clarity app provides retrospective data analysis that reveals patterns not obvious from real-time monitoring. Ambulatory Glucose Profile reports, time-in-range statistics, and daily overlay graphs help users and their healthcare providers identify recurring glucose patterns that inform treatment adjustments. These reports can be shared directly with healthcare providers, facilitating data-driven clinical conversations.
Dexcom systems are FDA-approved for diabetes management including insulin dosing decisions, meaning that users can base their insulin doses on CGM readings without confirmatory finger-stick testing in most situations. This regulatory distinction matters significantly for people with diabetes who depend on accurate glucose data for medication dosing.
For wellness users, Dexcom offers the Stelo system — a consumer-focused CGM designed specifically for people without insulin-dependent diabetes. Stelo uses the same sensor technology but presents data through a wellness-oriented app that emphasizes glucose response to meals, exercise, and lifestyle factors rather than clinical diabetes management features.
FreeStyle Libre Systems
Abbott's FreeStyle Libre system pioneered the "flash glucose monitoring" category and remains the most widely used CGM globally by total user count. The FreeStyle Libre 3 represents the current generation, offering a circular sensor smaller than a penny that provides real-time continuous glucose readings every minute — the most frequent reading interval of any consumer CGM.
The FreeStyle Libre 3 achieves competitive accuracy with a MARD that falls within the clinical-grade range suitable for diabetes management. The sensor lasts up to 14 days — the longest wear time among current CGMs — reducing the frequency and cost of sensor replacements. The sensor is factory-calibrated, requiring no finger-stick calibrations during the wear period.
One of the Libre system's distinguishing features is its accessibility strategy. Abbott has pursued aggressive pricing and broad insurance coverage, making the FreeStyle Libre available to a wider population of diabetic patients than higher-priced competitors. In many insurance plans, the Libre carries lower copays than competing CGM systems, and over-the-counter availability in some markets removes the prescription barrier entirely.
The LibreView platform provides cloud-based data management where patients and healthcare providers can access glucose reports remotely. The Ambulatory Glucose Profile and other standardized reports facilitate clinical review between appointments, and the platform supports multiple users on a single healthcare provider account for efficient panel management.
For wellness users, the FreeStyle Libre offers an accessible entry point into continuous glucose monitoring at a lower price than most alternatives. While the companion app focuses primarily on clinical diabetes management, the raw glucose data provides the same dietary and lifestyle insights that wellness users seek.
Wellness-Focused CGM Platforms
A new category of companies has emerged that pair clinical-grade CGM hardware — typically FreeStyle Libre or Dexcom sensors — with custom software platforms designed specifically for the wellness market. These platforms reframe glucose data from disease management into metabolic optimization, targeting health-conscious consumers who want to understand their individual glucose responses.
Levels positions itself as a metabolic health platform that uses CGM data to score meals, identify optimal food choices, and track metabolic fitness over time. Each meal receives a numerical score based on the glucose response it triggers, creating a simple feedback mechanism that helps users learn which foods their body handles well and which cause excessive glucose spikes. The Zone Score provides a daily summary of how well you maintained stable glucose throughout the day. Levels partners with healthcare providers to prescribe the underlying CGM sensor, adding a prescription cost to the platform subscription.
Nutrisense combines CGM monitoring with access to registered dietitians who review your glucose data and provide personalized nutritional guidance. This human coaching layer distinguishes Nutrisense from purely algorithmic platforms, as the dietitians can contextualize glucose patterns within your broader health goals, dietary preferences, and lifestyle constraints. The monthly subscription includes the CGM sensors and a defined number of dietitian consultations.
January AI takes a predictive approach, using artificial intelligence trained on glucose data from hundreds of thousands of meals to predict your glucose response to specific foods before you eat them. The app displays predicted glucose curves for menu items and recipes, helping you make food choices proactively rather than reactively learning from post-meal spikes.
These wellness platforms typically cost between $150 and $400 per month when factoring in sensor costs and subscription fees. The recurring expense limits their accessibility and raises the practical question of how long continuous monitoring is necessary for a metabolically healthy individual to capture the dietary insights the technology provides.
Key Comparison Metrics
When comparing CGM systems, several metrics matter most for your selection decision. Accuracy, as measured by MARD, should be your first consideration for diabetes management where dosing decisions depend on reliable readings. For wellness use where the goal is pattern recognition rather than precise numerical accuracy, modest accuracy differences between systems become less clinically significant.
Sensor wear time affects both convenience and cost. A 14-day sensor requires half as many insertions and half the sensor expense as a 7-day sensor over the same period. For people who find sensor insertion unpleasant or who are cost-sensitive, longer wear time provides meaningful advantages.
Real-time versus flash monitoring describes whether the system pushes glucose data to your phone continuously or requires you to scan the sensor to obtain a reading. Current-generation systems from both major manufacturers now provide real-time continuous data, but older models — still available and still prescribed — may require scanning.
Alert and alarm capabilities matter most for people with diabetes at risk for hypoglycemia or severe hyperglycemia. Customizable threshold alerts that sound even when your phone is on silent can prevent dangerous glucose excursions during sleep or when you are not actively monitoring your app. Wellness users typically have less need for urgent alerts since their glucose is unlikely to reach dangerous levels.
Smartphone compatibility should be verified before purchase, as not all CGM apps support all phone models. Check the manufacturer's compatibility list against your specific device and operating system version to ensure reliable connectivity.
Using CGM Data Effectively
Wearing a CGM produces an overwhelming volume of data that can either illuminate your metabolic health or create confusion and anxiety depending on how you approach interpretation. Effective CGM use requires understanding which patterns matter and which fluctuations are normal.
Post-meal glucose rises are entirely physiological and expected. After eating carbohydrate-containing food, blood glucose rises as the carbohydrates are digested and absorbed. In a metabolically healthy person, glucose typically peaks 30 to 60 minutes after eating and returns to baseline within two to three hours. The magnitude of the peak — how high glucose rises — and the time to return to baseline provide the meaningful data points, not the fact that glucose rose at all.
For people with diabetes, the primary metrics that correlate most strongly with long-term health outcomes are time in range — the percentage of the day spent with glucose between 70 and 180 milligrams per deciliter — and glucose variability, measured by coefficient of variation or standard deviation. Maximizing time in range while minimizing swings between high and low values represents the practical goal of diabetes CGM use. The American Diabetes Association recommends targeting at least 70 percent time in range for most adults with Type 2 diabetes.
For wellness users, the most actionable insights come from meal experiments — eating specific foods and observing your glucose response. Testing the same meal at different times of day reveals circadian effects on glucose metabolism. Comparing your response to white rice versus brown rice, fruit versus fruit with protein, or a meal after exercise versus the same meal without exercise teaches you practical nutritional strategies personalized to your physiology.
Overnight glucose patterns reveal information about metabolic health that daytime monitoring alone cannot provide. A flat, stable overnight glucose trace suggests healthy insulin sensitivity and liver glucose regulation. Significant overnight glucose rises — sometimes called the dawn phenomenon — may indicate developing insulin resistance worth discussing with your healthcare provider even in non-diabetic individuals.
Cost Analysis and Insurance Coverage
CGM costs vary dramatically depending on whether you have insurance coverage, which system you use, and whether you access sensors through clinical or wellness channels. Understanding the full cost picture helps you make a financially informed decision.
For diabetic patients with insurance coverage, out-of-pocket CGM costs vary by plan but typically range from $30 to $75 per month after insurance copays for covered systems. Most commercial insurance plans and Medicare now cover CGM for patients with diabetes who meet clinical criteria including insulin use or documented hypoglycemia risk. Prior authorization requirements vary by insurer, and your endocrinologist or primary care provider handles this process.
Without insurance, CGM sensors carry retail prices of approximately $75 to $100 per sensor. With sensor replacement every 7 to 14 days, monthly out-of-pocket costs range from $150 to $400 for the sensors alone, plus any transmitter costs for systems with separate transmitter components.
Wellness CGM platforms add subscription fees of $50 to $199 per month on top of sensor costs, bringing total monthly expenses to $200 to $400 or more. Some platforms include sensor costs in their subscription pricing, simplifying the financial calculation. Others require separate sensor procurement through a partnered healthcare provider or pharmacy.
The cost-benefit calculation differs fundamentally between diabetic and wellness use. For diabetic patients, CGM data directly informs treatment decisions that affect health outcomes and can prevent costly complications — the investment pays for itself many times over in avoided emergency department visits, hospitalizations, and long-term complications. For wellness users, the value proposition depends on how effectively you translate the data into lasting dietary and lifestyle changes that persist after you stop wearing the sensor.
Making Your CGM Decision
For people with Type 1 diabetes, the Dexcom G7 offers the best combination of accuracy, real-time alerts, and insulin dosing approval. The share feature adds safety for families, and Dexcom's integration with insulin pumps creates closed-loop automated insulin delivery systems that represent the current pinnacle of diabetes technology.
For people with Type 2 diabetes, both the Dexcom G7 and FreeStyle Libre 3 provide clinically appropriate accuracy for glucose management. The FreeStyle Libre's lower cost and 14-day sensor life offer economic advantages that may determine the choice for budget-conscious users or those whose insurance favors one system over the other.
For wellness users exploring metabolic health, the optimal strategy may involve a time-limited CGM experiment rather than indefinite continuous monitoring. Wearing a CGM for two to three months provides sufficient data to identify your individual food responses, learn which dietary patterns maintain glucose stability, and develop personalized eating habits based on your actual metabolic data. After this learning period, most of the actionable insights have been captured, and ongoing monitoring yields diminishing returns.
Regardless of which system you choose, the technology works only as well as your engagement with the data it produces. A CGM that stays in your nightstand drawer provides zero value, while even the most basic system worn consistently and reviewed thoughtfully can transform your understanding of how your body responds to the food you eat, the exercise you perform, and the lifestyle you lead.
Sources and Further Reading
Health and Beyond uses reputable medical and scientific sources where possible. These links support or expand on the topics discussed above.
- FDA-approvedfda.gov
- American Diabetes Associationdiabetes.org
